Plasmatic markers for early diagnostic and treatment decisions in ischemic stroke
- PMID: 26366222
- PMCID: PMC4564040
Plasmatic markers for early diagnostic and treatment decisions in ischemic stroke
Abstract
A neurologic deficit of sudden onset conforming to a vascular territory is a clear clinical indication that a patient suffers from an acute stroke. However, the imagistic diagnostic confirmation is not always readily available. We are now able to offer comprehensive medical support for the patient after an acute stroke and to make a prodigious rehabilitation program after the damage is done, but this is not offering the chance for improvement. An opportunity to better diagnose ischemic stroke seems to be available by using neuronal biomarkers. Extensive research is being conducted in this field and useful information is beginning to gather. This mini-review aims to highlight selected studies that appear to be of particular interest for the clinical neurologist. The most promising biomarkers (or rather panels of biomarkers) are presented with theirs clinical usefulness and limitations.
Keywords: biomarker panel; early diagnosis; ischemic stroke; neuronal biomarker.
References
-
- Whiteley W, Tseng MC, Sandercock P. Blood biomarkers in the diagnosis of ischemic stroke: a systematic review. Stroke. 2008;39:2902–2909. - PubMed
-
- Brouns R, De Deyn PP. The complexity of neurobiological processes in acute ischemic stroket. Clin Neurol Neurosurg. 2009;111:483–495. - PubMed
-
- Saenger KA, Christenson RH. Stroke Biomarkers: Progress and Challenges for Diagnosis, Prognosis, Differentiation, and Treatment. Clinical Chemistry. 2010 Jan;56,1:21–33. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical